CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial

Overview of attention for article published in Genetics in Medicine, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source
twitter: 25 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 146 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Genética Médica Querétaro, 11 Feb 2019

Intermediate and poor metabolizers benefit from CYP2D6 genotype-guided pain management https://goo.gl/9DNFbY

Genetics in Medicine, 11 Feb 2019

Intermediate and poor metabolizers benefit from CYP2D6 genotype-guided pain management https://goo.gl/9DNFbY

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.